The first-ever daily pill to help prevent against HIV was approved Monday by US regulators for use in uninfected adults who are at risk for getting the virus that causes AIDS. Truvada, made by Gilead Sciences in California, has been on the market since 2004 and was approved by the Food and Drug Administration for a new use as a tool to help ward off HIV in otherwise healthy people, in combination with safe sex and regular testing. The pill as pre-exposure prophylaxis (PrEP) has been hailed by some AIDS experts as a potent new tool against human immunodeficiency virus,
No comments:
Post a Comment
EAGLE EYE REPORT CROSS-FIRE AND DISCLAIMER:
Comments or opinions made here are not those of the publisher.
Publisher is not liable for the comments or opinions expressed by readers.
Be bold and include your name at the end of your comments.
No abusive, racist, or discriminatory comments.